Home › Therapeutic areas › Neurology › Fragile X Syndrome
Fragile X Syndrome (1 companies)
Companies with an active program in Fragile X Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies | Neurology Rare | 1 | Phase 3 | $1.41B | 4 |
No companies match.